Skip to main content

Table 3 Characteristic analysis on M. pneumoniae cases during epidemic and post-epidemic. Data were represented as n (%) in total cases, and as n (positivity, %) in M. pneumoniae cases

From: Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016

Characteristic

Epidemic

Post-epidemic

Total

M. pneumoniae cases

P value

Total

M. pneumoniae cases

P value

Age, median (IQR)

9 (30)

11 (20)

 

39 (58)

10 (19)

 

 Children

2534 (63.4)

604 (23.8)

<  0.001

1449 (37.8)

182 (12.6)

< 0.001

 Adults

1464 (36.6)

267 (18.2)

2388 (62.2)

74 (3.1)

Gender

  

0.145

  

0.102

 Female

1889 (47.2)

431 (22.8)

 

1625 (42.4)

121 (7.4)

 

 Male

2109 (52.8)

440 (20.9)

 

2212 (57.6)

135 (6.1)

 

Sample types

  

0.39

  

< 0.001

 Oropharyngeal swab

3265 (81.7)

705 (21.6)

 

1931 (50.3)

178 (9.2)

 

 Sputum

675 (16.9)

151 (22.4)

 

1615 (42.1)

74 (4.6)

 

 Balf a

54 (1.4)

15 (27.8)

 

278 (7.2)

4 (1.4)

 

 Others

4 (0.1)

0 (0)

 

13 (0.4)

0 (0)

 

Site of care

  

0.581

  

< 0.001

 Outpatients

2041 (51.1)

431 (21.1)

 

1386 (36.1)

100 (7.2)

 

 Wards

1807 (45.2)

426 (23.6)

 

1964 (51.2)

156 (7.9)

 

 RICU and EICU

96 (2.4)

11 (11.5)

 

261 (6.8)

0 (0)

 

 Other ICUs

54 (1.4)

3 (5.6)

 

226 (5.9)

0 (0)

 
  1. aBalf: bronchoalveolar lavage fluid
  2. P value: statistical analyses were performed within M. pneumoniae cases